期刊文献+

观察比索洛尔、依那普利联合螺内酯治疗风湿性心脏病慢性心力衰竭临床疗效 被引量:12

原文传递
导出
摘要 目的观察比索洛尔、依那普利联合螺内酯治疗风湿性心脏病慢性心力衰竭的临床疗效。方法选择2011年1月至2013年1月间新密市第一人民医院诊治的风湿性心脏病慢性心力衰竭患者42例,根据随机数字法将其分为对照组和观察组,每组21例,分别给予常规治疗以及比索洛尔、依那普利和螺内酯联合治疗,对两组临床疗效、不良反应进行观察和比较。结果与对照组相比,观察组总有效率明显升高,差异有统计学意义(P<0.05)。治疗期间两组均无明显不良反应。结论比索洛尔、依那普利和螺内酯联合治疗风湿性心脏病慢性心力衰竭的疗效显著,安全性高,值得临床广泛推广。
作者 孟金平
出处 《临床医学》 CAS 2013年第11期48-49,共2页 Clinical Medicine
  • 相关文献

参考文献3

二级参考文献51

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 2柯元南.高血压的联合治疗.中华心血管病杂志,2008,36:31-33.
  • 3Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Updata for the Diagnosis and Management of Chronic Heart Failure in the Adult-Summary Article : A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure ) : Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society[J]. Circulation, 2005, 112(12) : 1825 - 1852.
  • 4Chan AK, Sanderson JE, Wang T, et al. Aldosterone receptor antagonist induces reverse remodeling when added to antigenson reeeptor blockade in chronic heart failure[ J]. J Am Coll Cardio, 2007, 50(7) :591 -596.
  • 5Tang WH, Parameswaran AC, Maroo AP, et al. Aldosterone receptor antagonizes in the medical management of chronic heart iailure [J]. Mayo Clin Proc, 2005, 80(12) :1623 - 1630.
  • 6Zannad F, Alia F, Dousset B, et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure insights from the randomized alactone evaluation study ( RALES). Rales Investigators [ J ]. Circulation, 2000, 102 (22) :2700 - 2706 .
  • 7Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the aduh : executive summary. A report of the ACC/AHA task force on practice guidelines[ J]. J Am Collcardio, 2001 , 35(2) :101 -2113.
  • 8Benetos A,Adamopoulos C,Argyriadis P, et al. Clinical results with bisoprolol 2. 5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly [ J]. J Hypertens Suppl, 2002, 20 (1) :S21 -$25.
  • 9Gluckman TJ, Sachaev M, Schulman SP, et al. A simplified approach to the management of non-ST-segment elevation in acute coronary syndrome[ J]. JAMA, 2005, 293 ( 3 ) :349 - 357.
  • 10Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L

共引文献3784

同被引文献52

  • 1Babua C, Kalyesubula R,Okello E,et al. Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study [J]. BMC Neph- rol,2015,16(1) :l-6.
  • 2Saxena A. Evaluation of acquired valvular heart disease by the pediatrician : when to follow, when to refer for intervention? Part I [ J ]. Indian J Pediatr, 2015,82 ( 11 ): 1033-1041.
  • 3Dillon J, Yakub MA,Kong PK,et al. Comparative longterm results of mitral valve repair in adults with chronic rheumatic disease and degenerative disease : is repair for ''burnt-out" rheumatic disease still inferior to repair for degenerative disease in the current era? [ J ]. J Thorac Cardiovasc Surg,2015,149(3) :771-779.
  • 4Harikrishnan S,Sanjay G,Anees T,et al. Clinical pres-entation ,management, in - hospital and 90 - day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry[ J]. Eur J Heart Fail,2015,17(8) :794-800.
  • 5Ding N,Zhang X, Wang H,et al. Elimination of central sleep apnea by cardiac valve replacement : a continuous follow-up study in patients with rheumatic valvular heart disease[J]. Sleep Medicine,2015,16( Suppl 1) :7-8.
  • 6Ding N,Ni BQ,Zhang XL,et al. Prevalence and risk factors of sleep disordered breathing in patients with rheumatic valvular heart disease [ J ]. J Clin Sleep Med, 2013 , 9(8) :781-787.
  • 7马禄重.依那普利、美托洛尔联合治疗慢性心力衰竭临床探讨[J].中国现代药物应用,2010,4(13):126-127. 被引量:9
  • 8杨晴.依那普利联合螺内酯对慢性心力衰竭患者氧化应激状态的影响[J].中国现代医生,2010,48(33):62-64. 被引量:6
  • 9潘晓琼.抗高血压药在我院应用的合理性分析[J].中国医药导报,2011,8(10):143-145. 被引量:7
  • 10陈锐祥,邓裕勤.富马酸比索洛尔长期治疗高血压过程中对心脏保护的临床作用[J].中外医学研究,2011,9(15):54-55. 被引量:13

引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部